Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years.

MedStar author(s):
Citation: European Journal of Surgical Oncology. 46(10 Pt A):1908-1911, 2020 10.PMID: 32418756Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Adenocarcinoma/di [Diagnosis] | *Appendiceal Neoplasms/di [Diagnosis] | *Diagnostic Errors | *Neoplasms, Unknown Primary/di [Diagnosis] | *Peritoneal Neoplasms/di [Diagnosis] | Adenocarcinoma/sc [Secondary] | Adenocarcinoma/th [Therapy] | Adult | Aged | Antineoplastic Combined Chemotherapy Protocols/tu [Therapeutic Use] | Appendiceal Neoplasms/pa [Pathology] | Colonoscopy | Cytoreduction Surgical Procedures | Doxorubicin/ad [Administration & Dosage] | Endoscopy, Digestive System | Female | Fluorouracil/ad [Administration & Dosage] | Humans | Hyperthermic Intraperitoneal Chemotherapy | Immunohistochemistry | Laparotomy | Male | Middle Aged | Mitomycin/ad [Administration & Dosage] | Neoplasms, Unknown Primary/th [Therapy] | Peritoneal Neoplasms/sc [Secondary] | Peritoneal Neoplasms/th [Therapy] | Tomography, X-Ray ComputedYear: 2020Local holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:2002-2007ISSN:
  • 0748-7983
Name of journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyAbstract: CONCLUSION: Peritoneal carcinomatosis of unknown primary site was caused by an occult appendiceal adenocarcinoma in 36% of our patients. This error in diagnosis may lead to suboptimal treatment. Surgical exploration to visualize the anatomic site of the appendix should occur prior to making a definitive diagnosis of peritoneal carcinomatosis of unknown primary site. Copyright (c) 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.INTRODUCTION: Peritoneal carcinomatosis may be diagnosed by cytology or CT-guided biopsy, but routine radiologic and endoscopic workup not reveal a primary site. The clinical condition is referred to as peritoneal carcinomatosis of unknown primary site.METHODS: Over a 30-year time interval all patients treated with an initial diagnosis of carcinomatosis of unknown primary site were managed on a special clinical pathway. Upper gastrointestinal endoscopy, colonoscopy, and abdominal and pelvic CT were performed. Immunostains suggested a gastrointestinal origin of the carcinomatosis. After these tests, exploratory laparotomy was performed.RESULTS: Twenty-five patients fulfilled the criteria for peritoneal carcinomatosis of unknown primary site and all 25 of these patients underwent an exploratory laparotomy. Special attention to the anatomic site of the appendix occurred during the exploratory laparotomy. No site within the gastrointestinal tract including a non-cancerous appendix was observed in 9 patients (36%). In 7 patients (28%), the carcinomatosis was so extensive that an adequate exploration to determine a primary site was not possible. In a third group of 9 patients (36%), exploratory laparotomy revealed an occult appendiceal malignancy.All authors: Sugarbaker PHOriginally published: European Journal of Surgical Oncology. 2020 Apr 28Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2020-07-09
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32418756 Available 32418756

Available online from MWHC library: 1995 - present, Available in print through MWHC library:2002-2007

CONCLUSION: Peritoneal carcinomatosis of unknown primary site was caused by an occult appendiceal adenocarcinoma in 36% of our patients. This error in diagnosis may lead to suboptimal treatment. Surgical exploration to visualize the anatomic site of the appendix should occur prior to making a definitive diagnosis of peritoneal carcinomatosis of unknown primary site. Copyright (c) 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

INTRODUCTION: Peritoneal carcinomatosis may be diagnosed by cytology or CT-guided biopsy, but routine radiologic and endoscopic workup not reveal a primary site. The clinical condition is referred to as peritoneal carcinomatosis of unknown primary site.

METHODS: Over a 30-year time interval all patients treated with an initial diagnosis of carcinomatosis of unknown primary site were managed on a special clinical pathway. Upper gastrointestinal endoscopy, colonoscopy, and abdominal and pelvic CT were performed. Immunostains suggested a gastrointestinal origin of the carcinomatosis. After these tests, exploratory laparotomy was performed.

RESULTS: Twenty-five patients fulfilled the criteria for peritoneal carcinomatosis of unknown primary site and all 25 of these patients underwent an exploratory laparotomy. Special attention to the anatomic site of the appendix occurred during the exploratory laparotomy. No site within the gastrointestinal tract including a non-cancerous appendix was observed in 9 patients (36%). In 7 patients (28%), the carcinomatosis was so extensive that an adequate exploration to determine a primary site was not possible. In a third group of 9 patients (36%), exploratory laparotomy revealed an occult appendiceal malignancy.

English

Powered by Koha